Ken Griffin Quanterix Corp Transaction History
Citadel Advisors LLC
- $559 Billion
- Q4 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Quanterix Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 12,700 shares of QTRX stock, worth $95,885. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,700
Previous 10,100
25.74%
Holding current value
$95,885
Previous $130,000
3.85%
% of portfolio
0.0%
Previous 0.0%
Shares
24 transactions
Others Institutions Holding QTRX
# of Institutions
163Shares Held
34.9MCall Options Held
121KPut Options Held
41K-
Ameriprise Financial Inc Minneapolis, MN3.21MShares$24.2 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.14MShares$23.7 Million0.0% of portfolio
-
Portolan Capital Management, LLC Boston, MA2.59MShares$19.5 Million2.08% of portfolio
-
Alliancebernstein L.P. New York, NY2.44MShares$18.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.22MShares$16.7 Million0.0% of portfolio
About Quanterix Corp
- Ticker QTRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 36,987,600
- Market Cap $279M
- Description
- Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...